BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster than those assessed with TURBT alone ...
The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...
Dame Tracey Emin revealed on BBC 100 Women that Elton John was the first person to congratulate her after she was made a dame ...
Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.
StarsInsider on MSN14h
Bladder cancer: the signs, symptoms, and treatmentsBladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...
Developed by Professor Guillermo Ameer, the material improves bladder tissue regeneration and overall function better than ...
A team of Northwestern scientists has developed an electroactive "scaffolding" material that improves bladder tissue ...
Sens. Chuck Schumer and Kirsten Gillibrand, and U.S. Rep. Tim Kennedy, met with the DEC to learn more about pollution from the Goodyear plant in Niagara Falls.
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Adding a PD-1 antibody to BCG led to improved event-free survival in patients with non–muscle invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback